Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 171757206
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 585,000.00 · Class: 2.0%
- Commodore Capital Master LP
Shares: 585,000.00 · Class: 2.0%
- Robert Egen Atkinson
Shares: 585,000.00 · Class: 2.0%
- Michael Kramarz
Shares: 585,000.00 · Class: 2.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-25-000026
- Form type
- SCHEDULE 13G/A
- Filer
- Cidara Therapeutics, Inc.
- CIK
- CIK 1610618
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership